Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90


The anti-tumor effect of A3 adenosine receptors is potentiated by pulsed electromagnetic fields in cultured neural cancer cells.

Vincenzi F, Targa M, Corciulo C, Gessi S, Merighi S, Setti S, Cadossi R, Borea PA, Varani K.

PLoS One. 2012;7(6):e39317. doi: 10.1371/journal.pone.0039317. Epub 2012 Jun 25.


Pulsed electromagnetic fields increased the anti-inflammatory effect of A₂A and A₃ adenosine receptors in human T/C-28a2 chondrocytes and hFOB 1.19 osteoblasts.

Vincenzi F, Targa M, Corciulo C, Gessi S, Merighi S, Setti S, Cadossi R, Goldring MB, Borea PA, Varani K.

PLoS One. 2013 May 31;8(5):e65561. doi: 10.1371/journal.pone.0065561. Print 2013.


Characterization of adenosine receptors in bovine chondrocytes and fibroblast-like synoviocytes exposed to low frequency low energy pulsed electromagnetic fields.

Varani K, De Mattei M, Vincenzi F, Gessi S, Merighi S, Pellati A, Ongaro A, Caruso A, Cadossi R, Borea PA.

Osteoarthritis Cartilage. 2008 Mar;16(3):292-304. Epub 2007 Aug 16.


A2A and A3 adenosine receptor expression in rheumatoid arthritis: upregulation, inverse correlation with disease activity score and suppression of inflammatory cytokine and metalloproteinase release.

Varani K, Padovan M, Vincenzi F, Targa M, Trotta F, Govoni M, Borea PA.

Arthritis Res Ther. 2011;13(6):R197. doi: 10.1186/ar3527. Epub 2011 Dec 6.


Normalization of A2A and A3 adenosine receptor up-regulation in rheumatoid arthritis patients by treatment with anti-tumor necrosis factor alpha but not methotrexate.

Varani K, Massara A, Vincenzi F, Tosi A, Padovan M, Trotta F, Borea PA.

Arthritis Rheum. 2009 Oct;60(10):2880-91. doi: 10.1002/art.24794.


A2A adenosine receptor overexpression and functionality, as well as TNF-alpha levels, correlate with motor symptoms in Parkinson's disease.

Varani K, Vincenzi F, Tosi A, Gessi S, Casetta I, Granieri G, Fazio P, Leung E, MacLennan S, Granieri E, Borea PA.

FASEB J. 2010 Feb;24(2):587-98. doi: 10.1096/fj.09-141044. Epub 2009 Sep 23.


Effect of pulsed electromagnetic field exposure on adenosine receptors in rat brain.

Varani K, Vincenzi F, Targa M, Corciulo C, Fini M, Setti S, Cadossi R, Borea PA.

Bioelectromagnetics. 2012 May;33(4):279-87. doi: 10.1002/bem.20704. Epub 2011 Oct 19.


Adenosine inhibits tumor necrosis factor-alpha release from mouse peritoneal macrophages via A2A and A2B but not the A3 adenosine receptor.

Kreckler LM, Wan TC, Ge ZD, Auchampach JA.

J Pharmacol Exp Ther. 2006 Apr;317(1):172-80. Epub 2005 Dec 9.


Adenosine receptors and cancer.

Fishman P, Bar-Yehuda S, Synowitz M, Powell JD, Klotz KN, Gessi S, Borea PA.

Handb Exp Pharmacol. 2009;(193):399-441. doi: 10.1007/978-3-540-89615-9_14. Review.


Electromagnetic fields (EMFs) and adenosine receptors modulate prostaglandin E(2) and cytokine release in human osteoarthritic synovial fibroblasts.

Ongaro A, Varani K, Masieri FF, Pellati A, Massari L, Cadossi R, Vincenzi F, Borea PA, Fini M, Caruso A, De Mattei M.

J Cell Physiol. 2012 Jun;227(6):2461-9. doi: 10.1002/jcp.22981.


A₃ receptors are overexpressed in pleura from patients with mesothelioma and reduce cell growth via Akt/nuclear factor-κB pathway.

Varani K, Maniero S, Vincenzi F, Targa M, Stefanelli A, Maniscalco P, Martini F, Tognon M, Borea PA.

Am J Respir Crit Care Med. 2011 Feb 15;183(4):522-30. doi: 10.1164/rccm.201006-0980OC. Epub 2010 Sep 24.


Effect of low frequency electromagnetic fields on A2A adenosine receptors in human neutrophils.

Varani K, Gessi S, Merighi S, Iannotta V, Cattabriga E, Spisani S, Cadossi R, Borea PA.

Br J Pharmacol. 2002 May;136(1):57-66.


Differential expression of adenosine A3 receptors controls adenosine A2A receptor-mediated inhibition of TLR responses in microglia.

van der Putten C, Zuiderwijk-Sick EA, van Straalen L, de Geus ED, Boven LA, Kondova I, IJzerman AP, Bajramovic JJ.

J Immunol. 2009 Jun 15;182(12):7603-12. doi: 10.4049/jimmunol.0803383.


Expression and functional role of adenosine receptors in regulating inflammatory responses in human synoviocytes.

Varani K, Vincenzi F, Tosi A, Targa M, Masieri FF, Ongaro A, De Mattei M, Massari L, Borea PA.

Br J Pharmacol. 2010 May;160(1):101-15. doi: 10.1111/j.1476-5381.2010.00667.x. Epub 2010 Mar 19.


Multiple sclerosis lymphocytes upregulate A2A adenosine receptors that are antiinflammatory when stimulated.

Vincenzi F, Corciulo C, Targa M, Merighi S, Gessi S, Casetta I, Gentile M, Granieri E, Borea PA, Varani K.

Eur J Immunol. 2013 Aug;43(8):2206-16. doi: 10.1002/eji.201343314. Epub 2013 Jun 3.


Alteration of A(3) adenosine receptors in human neutrophils and low frequency electromagnetic fields.

Varani K, Gessi S, Merighi S, Iannotta V, Cattabriga E, Pancaldi C, Cadossi R, Borea PA.

Biochem Pharmacol. 2003 Nov 15;66(10):1897-906.


A(2A) adenosine receptors are differentially modulated by pharmacological treatments in rheumatoid arthritis patients and their stimulation ameliorates adjuvant-induced arthritis in rats.

Vincenzi F, Padovan M, Targa M, Corciulo C, Giacuzzo S, Merighi S, Gessi S, Govoni M, Borea PA, Varani K.

PLoS One. 2013;8(1):e54195. doi: 10.1371/journal.pone.0054195. Epub 2013 Jan 11.


Imidazo[2,1-i]purin-5-ones and related tricyclic water-soluble purine derivatives: potent A(2A)- and A(3)-adenosine receptor antagonists.

Müller CE, Thorand M, Qurishi R, Diekmann M, Jacobson KA, Padgett WL, Daly JW.

J Med Chem. 2002 Aug 1;45(16):3440-50.

Items per page

Supplemental Content

Write to the Help Desk